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Summary 
Documented interactions among members of the Myc 
superfamily support a yin-yang model for the regula- 
tion of Myc-responsive genes in which t ransactivation- 
competent Myc-Max heterodimers are opposed by re- 
pressive Mxi l -Max or Mad-Max complexes. Analysis 
of mouse taxi1 has led to the identification of two mxil 
transcript forms possessing open reading frames that 
differ in their capacity to encode a short amino- 
terminal e-helical domain. The presence of this seg- 
ment dramatically augments the suppressive potential 
of Mxil and allows for association with a mammalian 
protein that is structurally homologous to the yeast 
transcriptional repressor SIN3. These findings provide 
a mechanistic basis for the antagonistic actions of 
Mxil on Myc activity that appears to be mediated in part 
through the recruitment of a putative transcriptional 
repressor. 
Introduction 
Members of the myc family of nuclear proto-oncogenes (c-, 
N-, and L-myc) play central roles in the control of normal 
growth and development and in genetic pathways linked 
to cellular transformation and apoptotic cell death (Evan 
and Littlewood, 1993; Morgenbesser and DePinho, 1994). 
Accumulating structural, biochemical, and genetic evi- 
dence affords the view that the function of Myc family onco- 
proteins in these diverse processes relates in part to their 
roles as sequence-specific transcription factors (for re- 
views see Kato and Dang, 1992; Torres et al., 1992). Myc 
family oncoproteins appear to influence the expression of 
growth-promoting enes, such as those involved in DNA 
synthesis (Bello-Fernandez et al., 1993) and cell cycle reg- 
ulation (Jansen-Durr et al., 1993), in a positive manner. 
Myc may also play a repressive role in the regulation of 
some genes through interaction with an initiation factor of 
the general transcriptional machinery (Roy et al., 1993). 
Myc family proteins possess a multifunctional amino- 
terminal domain with transactivation potential (Kato et al., 
1990), a region rich in basic amino acid residues responsi- 
ble for sequence-specific DNA-binding activity (Blackwell 
*The first wo authors contributed equally to this work. 
et al., 1990), and a carboxy-terminal -helical domain re- 
quired for dimerization with another basic region-helix- 
Ioop-helix-leucine zipper (bHLH-LZ) protein, Max (Black- 
wood and Eisenman, 1991; Prendergast et al., 1991). 
Many of the biochemical and biological activities of Myc 
appear to be highly dependent upon its association with 
Max (Blackwood and Eisenman, 1991 ; Prendergast et al., 
1991; Kretzner et al., 1992; Amati et al., 1993a, 1993b). 
In addition to its key role as an obligate partner in transacti- 
vation-competent Myc-Max complexes, Max may also re- 
press Myc-responsive genes through the formation of 
transactivation-inert complexes that are capable of bind- 
ing the Myc-Max recognition sequence (Blackwood et al., 
1992; Kato et al., 1992; Kretzner et al., 1992; Makela et 
al., 1992; Mukherjee et al., 1992; Prendergast et al., 1992; 
Ayer et al., 1993; Zervos et al., 1993). These complexes 
include Max-Max homodimers, whose DNA-binding activ- 
ity is subject to regulation by casein kinase II phosphoryla- 
tion (Berberich and Cole, 1992), and the recently de- 
scribed heterodimers Mad-Max (Ayer et al., 1993) and 
Mxil-Max (Zervos et al., 1993). Together, these function- 
ally interactive and structurally related bHLH-LZ proteins 
comprise an expanding Myc superfamily. 
The biochemical properties of the highly homologous 
MAD and MXll have led to a model for their regulation of 
Myc activity in which these two proteins compete with Myc 
for binding both to Max and to common target sequences 
(Ayer et al., 1993; Zervos et al., 1993). As such, the relative 
intracellular levels of Mad and Mxil in comparison to those 
of Myc influence the transcriptional activation of Myc- 
responsive genes through a dynamic interchange be- 
tween the formation of transactivation-inert (Mad-Max or 
Mxil-Max) and transactivation-competent (Myc-Max) 
complexes (Ayer et al., 1993; Zervos et al., 1993). The 
opposing relationship between Myc and Mad or Mxil de- 
rives further support from biological studies demonstrating 
that, during the approach of many cell lineages to the ter- 
minally differentiated state, MXl and MAD mRNA and pro- 
tein levels increase, while those of c-MYC decrease (Ayer 
et al., 1993; Ayer and Eisenman, 1993; Zervos et al., 1993; 
Larsson et al., 1994; Schreiber-Agus et al., 1994), and that 
overexpression of MXll and MAD can antagonize myc 
activity in cellular transformation assays (Lahoz et al., 
1994). The anti-oncogenic activity of Mad and Mxil ac- 
quires particular significance with the localization of MAD 
and MXI1 genes to chromosomal oci implicated in the 
genesis of several human cancers (Edelhoff et al., 1994; 
M. F. Seldin and R. A. D., unpublished data). 
Progress on the elucidation of the precise molecular 
actions of Myc at the level of Myc-responsive gene targets 
and on the relation of such actions to growth and differenti- 
ation has been hampered by the modest transactivation 
activity of Myc in available transcription reporter assays 
and by the limited repertoire of bona fide myc gene targets. 
As an alternative strategy to understanding the nature of 
the actions of Myc and of the functional relationships 
among members of the Myc superfamily, we and others 
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have used the rat embryo fibroblast (REF) cooperation 
assay (Land et al., 1983). This highly quantitative biologi- 
cal assay takes advantage of a long-recognized property 
of Myc, namely, its ability to cooperate with activated H-RAS 
(Val-12) to effect the malignant transformation of early- 
passage REFs. The REF cooperation assay has proven 
effective in the evaluation of candidate modulators of myc 
oncogenic potential, including the Max-associated pro- 
teins MAD and MXll (Lahoz et al., 1994), dominant nega- 
tive mutants of Myc (Mukherjee et al., 1992; Sawyers et al., 
1992), retinoblastoma (Rb), and other cell cycle regulators 
(Serrano et al., 1995). The functional impact of such modu- 
lators correlates well with their biochemical profiles and 
postulated mechanisms of action. For instance, Rb, which 
is thought o interact poorly with Myc in vivo, has a minimal 
suppressive effect on myclRAS-induced foci formation 
(E. G. Lahoz and R. A. D., unpublished data), while overex- 
pression of MAD or MXl leads to a profound reduction 
in transformation activity in a highly Myc-specific manner 
(Lahoz et al., 1994). 
In the course of investigating the basis of the anti- 
oncogenic activity of Mxil, we identified two mxil mRNAs 
that arise through alternative RNA processing and that 
encode proteins with dramatically different abilities to re- 
press myc-induced transformation. The capacity for strong 
repressive activity correlates with an amino-terminal ex- 
tension of 36 residues that is present in only one of the 
two Mxi protein forms. Significantly, use of the yeast two- 
hybrid interaction system showed that this highly con- 
served (z-helical "repression" domain of Mxil (and MAD) 
associates with a murine homolog of the yeast transcrip- 
tional repressor SIN3 (Nasmyth et al., 1987; Sternberg et 
al., 1987; Strich et al., 1989; Wang et al., 1990; Vidal et 
al., 1991; Wang and Stillman, 1993). Through coimmuno- 
precipitation studies in mammalian cells, Mxil and mouse 
Sin3 (roSin3) were shown to be part of a ternary complex 
that also included Max. As such, the antagonistic activity 
of Mxi may be executed not only through its competition 
with Myc for Max and common gene targets but, more 
importantly, through its association with a transcriptional 
repressor. 
Results 
Key Structural Features of Mouse mxil Transcripts 
and Putative Proteins 
Alternative Transcript Forms of the Mouse taxi1 Gene 
Possess Overlapping Open Reading Frames That 
Encode Mxil Proteins with Different Amino Termini 
Low stringency hybridization to mouse cDNA libraries em- 
ploying several human MXI1 probes resulted in the isola- 
tion of two different cDNA clones, lmxi-SR and tmxi-WR, 
that differ only in their 5' regions. As shown below, the 
putative proteins encoded by these two cDNAs have very 
different abilities to antagonize the transformation activity 
of Myc, hence the designations SR and WR for strong 
repressor and weak repressor, respectively. The organiza- 
tion of mouse genomic sequences encoding the 5' regions 
of the mxi-SR and mxi-WR cDNAs is consistent with the 
existence of a single mxil gene capable of producing the 
two mRNAs through alternative RNA processing (N. S.-A., 
H.-W. Lee, and R. A. D., unpublished data). 
Nucleic acid sequence analysis of the tmxi-SR cDNA 
clone revealed an ATG-initiated open reading frame (ORF) 
capable of encoding a protein of 228 amino acids with a 
predicted molecular size of 25,977 Da (Mxi-SR in Figure 
1A). That the predicted Mxi-SR protein indeed represents 
the mouse homolog of human MXll (Zervos et al., 1993; 
the human MXl clone was shown to be equivalent to mouse 
mxi-SR and not mouse mxi-WR) is supported by their 
shared amino acid identity of 96% compared with only 
61% when aligned with human MAD (Ayer et al., 1993). 
The second mxil cDNA clone, tmxi-WR, is identical to 
tmxi-SR in the nucleic acid sequences encoding residues 
37-228 of the tmxi-SR ORF and in its 3' untranslated re- 
gion (3'UTR). However, the 5'-most sequences of the tmxi- 
SR ORF are absent from tmxi-WR and are replaced by 
different sequences that do not encode an in-frame ORF. 
As a result, the putative protein encoded by tmxi-WR 
would likely initiate translation at an ATG that corresponds 
to a methionine at position 37 in the Mxi-SR protein (Mxi- 
WR in Figure 1A). 
The Mxi.SR Amino.Terminal Extension 
While mxi-SR and mxi-WR ORFs encode identical bHLH- 
LZ and carboxy-terminal regions, alternative utilization of 
5' sequences extends the mxil-SR ORF an additional 36 
amino acids beyond the mxil-WR ORF. This extension is 
highly conserved throughout vertebrate evolution, exhib- 
iting 100% similarity with human MXI 1 (Zervos et al., 1993) 
and 72% similarity with zebra fish Mxil (Schreiber-Agus 
et al., 1994) (Figure 1B; zebra fish not shown). Notably, 
this region is also highly homologous (78% similar) to an 
analogously positioned domain in human MAD (Ayer et al., 
1993) (Figure 1 B). The secondary structure of this Mxil-SR 
amino-terminal extension is predicted to be strongly (z-heli- 
cal, and the potential for (~ helicity is conserved in the human 
MXI, human MAD, and zebra fish Mxi amino-terminal 
regions as well. 
Mxi-SR and Mxi-WR Have Very Different Abilities 
to Repress Myc Transformation Activity 
We demonstrated previously that human MXI1 and MAD 
are potent inhibitors of myc/RAS cotransformation ofREFs; 
this effect was shown to be Myc specific (Lahoz et al., 
1994). In the present study, the quantitative nature of this 
biological assay was exploited to determine whether mxil- 
SR and mxil-WR differed in their inhibitory activities. Inhi- 
bition was assessed by comparing the number of trans- 
formed foci generated in cotransfections containing mouse 
c-myc and activated H-RAS in the presence or absence 
of an equimolar amount of various mxil expression con- 
structs in multiple independent experiments (Figure 2). 
In the first series of cotransfections, the mouse mxi-WR, 
mouse mxi-SR, and human MXI1 expression constructs 
were compared for their ability to repress c-myc/RAS onco- 
genic activity. The human MXI10RF used here was equiv- 
alent to the mouse mxil-SR form. As tabulated in Figure 
2B (experiments 1, 4, and 5), a significant reduction in 
the number of foci generated was observed when either 
mouse mxi-SR or human MXI1 was added to the c-myc/ 
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Figure 1. Structural Analysis of Mxi-SR and Mxi-WR Proteins 
(A) Alignment of mouse mxil-SR and mxi-WR and human MXl (Zervos 
et al., 1993) ORF sequences. Amino acid sequences (in single-letter 
code) were aligned using the Pileup program of the Genetics Computer 
Group sequence analysis software package (Devereux et al., 1984). 
Position 1 is assigned to the putative initiation codon in the mouse 
Mxil-SR protein, and dashes represent: residues in mouse Mxi-WR 
or human MXl that are identical to the mouse Mxil-SR residues. The 
basic region is enclosed by a box, the two helices of the HLH region 
are stippled, and conserved hydrophobic residues of the 17 region 
are marked by open inverted triangles. With respect to the Mxil basic 
region, arrows indicate residues that have been shown crystallographi- 
cally for Max (Ferre-D'Amare t al., 1993) and by site-directed mutagen- 
esis for E box-binding proteins (Fisher :et al., 1993, and references 
therein) to confer sequence-specific DNA recognition. The conserva- 
tion of Glu-76 and Arg-80 in mouse Mxi-SR is integral, as these resi- 
dues have been determined to contact the CG dinucleotide core of 
the E box specifically and thus serve to discriminate among the various 
CANNTG sequences. Residues that have been hypothesized to gov- 
ern the selection or dismissal of dimerization partners (Schreiber-Agus 
et al., 1994) are marked by asterisks. Specifically, the residues Arg-89 
on helix 1, Lys-113 on helix 2, and Glu-123 and G lu-136 on the LZ are 
predicted to lie along the interacting electrostatic surface, a pred ct on 
based on the Max crystal structure (Ferre-D'Amare t ai., 1993) and 
modeling comparisons of the various Mxil proteins (Schreiber-Agus 
et al., 1994). The amino acid sequence of human MXI1 was derived 
from our correction of its published nucleic acid sequence (replace- 
ment of CG residues at positions 293-294 w th GGC, inversion of CG 
residues at positions 389-390, and deletion of TA residues at post ons 
894-895 of the published human MXll cDNA sequence [Zervos et al., 
1993; see also erratum of paper as listed in References]). 
(B) Schematic maps of mouse Mxi-SR, mouse Mxi-WR, human MXl, 
and human MAD proteins are shown, with landmark regions indicated 
(closed box shows repressive region). Amino acid sequences were 
aligned as in (A) with dashes representing residues identical to the 
mouse Mxil-SR residues and dots in the sequence representing aps 
that were introduced to maximize homology. Shown here is an align- 
RAS cotransfections; this level of suppression was compa- 
rable to that reported previously for the human MXll gene 
(Lahoz et al., 1994). In contrast, a similarly designed ex- 
pression construct encoding mouse Mxi-WR exerted only 
a modest repressive effect upon c-Myc cotransformation 
activity, hence the suffix WR for weak repressor. On another 
level, when transformed cell lines were established from 
c-myclRASImouse mxi-SR or c-myclRASImouse mxi-WR 
foci and analyzed by Northern blotting analysis for expres- 
sion of introduced genes, each showed high levels of myc- 
and RAS-derived transcripts, but only myclRASImouse 
mxi-WR transformants showed abundant levels of taxi 
transcripts (data not shown). This observation suggests 
that strong selective pressure against mouse mxi-SR ex- 
pression exists du ring progression toward the transformed 
state, and only those foci that fail to express the introduced 
mouse mxi-SR gene survive the establishment process. 
To verify that the 5' ORF of mouse mxi-SR conferred 
strong repressive potential upon Mxi l  and to rule out the 
possibility that the diminished activity of mouse mxil-WR 
may have been due to a poor translational context of the 
downstream ATG, we assayed in c-myclRAS cotransfec- 
tions a mutant construct, mouse mxi-Arep, that was de- 
leted in-frame for most of the putative "repression domain" 
of mxil.SR. This construct was found to possess weak 
repressive potential similar to that of Mxi-WR and mark- 
edly reduced from that of Mxi-SR (experiments 2, 4, and 
5 in Figure 2B). Conversely, when sequences encoding 
the 36 residues of this domain of human MXl l  were ap- 
pended to the ORF of mouse mxil-WR, the resulting chi- 
meric construct exhibited a level of repression comparable 
to mouse mxil-SR (data not shown). In addition, a proline 
for leucine substitution at position 19 of the repressive 
domain of Mxi-SR (see Figure 1B) significantly diminished 
suppressive activity (experiments 3, 4, and 5 in Figure 2B); 
since proline residues are known to cause disruption of 
a-helical structures, this loss of function suggests that a 
helicity may be integral to amino-terminal functions. Aver- 
aged over multiple independent experiments (representa- 
tive ones employing the entire panel of mxi expression 
constructs are shown in experiments 4 and 5 in Figure 
2B), the fold suppression induced was 5.3 for human MXl, 
8.1 for mouse Mxi-SR, 1.74 for mouse Mxi-WR, 1.57 for 
mouse Mxi-Arep, and 1.78 for mouse Mxi-SR-pro. 
As these findings clearly indicated that the amino-termi- 
nal region of Mx i l -SR is essential for full anti-Myc activity, 
its modular nature was examined further by assaying 
whether fusion of this domain onto Max could enhance 
the repressive potential of Max. We and others have dem- 
onstrated previously that inclusion of hypermolar amounts 
of a max expression construct in cotransfections can in- 
ment of the domains that confer repressive activity upon mouse Mxi-SR 
and human MXI with a similarly positioned region in the human MAD 
amino terminus. This repression domain is absent from the weakly 
repressive Mxi-WR. The ~z-helical nature of this domain, as assessed 
by the PredictProtein algorithm (European Molecular Biology Labora- 
tory), results from the amphipathicity of these residues. The teucine 
residue (Leu-19) that was converted to a proline to make Mxi-SR-pro 
(discussed in Experimental Procedures) is marked by an asterisk. 
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Figure 2, Structure-Function A alysis of Various mxil Constructs as 
Assessed by Anti-Myc Activity in the REF Assay 
(A) Inserts used to generate the various mxi expression constructs 
utilized in (B) and (C) are shown schematically. Initiator codon of mxi- 
Sit is marked by an open inverted triangle, while that of mxi-WR is 
marked by a closed inverted triangle. Terminator codons are marked 
by asterisks. 
(B) Each primary plate was transfected with 2 I~g of the mouse c-myc 
expression construct, 2p.g of H-RAS (Val-12), 2 p.g of the appropriate 
mxiexpression construct (or empty vector) as indicated in the transfected 
DNA column, and 30 p_g of genomic arrier DNA. The total number 
of foci on six plates (derived from two transfected plates that were 
hibit transformation activity of myc family genes in the 
REF assay (Makela et al., 1992; Mukherjee et al., 1992; 
Prendergast et al., 1992), whereas addition of submolar 
amounts of the max construct can act to enhance mycl 
RAS transforming potential slightly (Prendergast et al., 
1992), presumably through the increased formation of 
transactivation-competent Myc-Max heterocomplexes. 
Based on these observations, the impact of submolar 
amounts of two expression constructs, one encoding 
mouse Max and the other encoding a chimeric protein in 
which the repression domain of Mxil-SR was fused in- 
frame to the bHLH-LZ and 3' ORF sequences of mouse 
Max (mmax-rep in Figure 2A), was examined in the REF 
assay. As shown in Figure 2C, addition of small amounts 
of the max expression construct did not alter the average 
number of loci per plate, whereas addition of the same 
amounts of the mouse max-rep construct exerted a pro- 
found repressive effect upon Myc cotransformation activ- 
ity. Notably, in multiple experiments, the level of repres- 
sion seen with the addition of an equimolar amount of 
mxi-SR to c-myclRAS cotransfections appeared to be at- 
tained with one eighth that amount of mouse max-rep. 
Although the precise basis for the greatly enhanced level 
of repression seen with mouse max-rep remains to be de- 
termined, it may relate to the extremely stable nature of 
the Max protein (Blackwood et al., 1992) as well as to 
the ability of the Max HLH-LZ region to associate with all 
members of Myc superfarnily (Blackwood and Eisenman, 
1991; Prendergast et al., 1991; Blackwood et al., 1992; 
Ayer et al., 1993; Zervos et al., 1993). That this enhanced 
repressive potential could have been secondary to our 
deletion of Max 5' ORF sequences (including phosphoryla- 
tion sites) was ruled out by the finding that a construct 
having Mxi-WR 5' ORF sequences appended onto the 
same Max 3' ORF sequences present in the mouse max- 
rep construct did not alter the average number of foci per 
plate when added in submolar amounts to myclRAS co- 
transfections (data not shown). 
Interaction of the Repression Domain with a 
Mammalian Homolog of Yeast SIN3 
The predicted co-helical configuration of the repressive do- 
main of Mxi (and MAD) proteins raised the possibility that 
the molecular mechanisms governing biological activities 
of the repressive domain may be executed through pro- 
tein-protein interactions. To identify proteins that associ- 
ate with these repression domains, a modified version of 
the yeast two-hybrid method (Vojtek et al., 1993) was em- 
ployed. The amino-terminal region of human MAD (Ayer 
split 1:3) was counted approximately 10days posttransfection in five 
separate xperiments. Abbreviations: Exp., experiment; ND, not deter- 
mined. 
(C) Each primary plate was transfected with 2 p.g of c-myc, 2 p.g of 
activated H-RAS, 30 p_g of genomic arrier DNA, and the indicated 
amount of one of two mouse max expression constructs, i.e., one wild 
type and the other in which the 5' ORF sequences of max (upstream 
of its basic region) were replaced with those of mxi-SR. The average 
number of foci per plate was determined approximately 10days post- 
transfection. 
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Figure 3. The Conserved Repressive Region of MAD and Mxi Identi- 
fies a Murine Homolog f Yeast SIN3 in Two-Hybrid Screens 
Partial sequence of the GAL4 fusion protein isolated from a ouse T 
cell lymphoma library by two-hybrid screens with a LexA bait con- 
taining human MAD repressive region sequences is shown. Amino 
acid sequences (in single-letter code) were aligned with the Gen tics 
Computer Group sequence analysis software package (Devereux et 
al., 1984). Between the mouse and the yeast (Wang et al., 1990; Vidal 
et al., 1991) SIN3 residues, vertical lines represent identity, colons 
represent high homology, and elipses represent weak similarity. 
Shown is the interacting region of mSin3, with helices of PAH2 outlined 
by boxes. The leucine residue inhelix 1 of PAH2 that was converted 
to a proline to generate Sin3-pro (see Experimental Procedures) is 
marked by an asterisk. 
et al., 1993) was fused in-frame to the LexA-DNA-binding 
domain (DBD), and the fusion protein encoded by this con- 
struct was used as a bait to screen for interacting fusion 
proteins encoded by a mouse T cell lymphoma cDNA li- 
brary subcloned in the GAL4 transactivation domain 
(TAD)-containing pACT vector. Approximately 4 x 106 
transformants were screened under selection for expres- 
sion of both fusion proteins, and 11 yeast clones were 
identified that exhibited growth in histidine-free media and 
activity in a 13-galactosidase filter assay. This phenotype 
is consistent with an interaction between the repressive 
domain-LexA bait and a cellular protein-GAL4 fusion that 
results in transactivation of two integrated reporter con- 
structs, the yeast HIS3 gene and the bacterial acZ gene, 
each containing LexA-binding sites in their promoters. Nu- 
cleic acid sequence analysis of the T cell-derived cDNA 
ORFs fused in-frame with the GAL4 TAD revealed that 
they all were capable of encoding a mammalian protein 
possessing 49% similarity (33% identity) to the yeast tran- 
scriptional repressor SIN3 (Wang et al., 1990; Vidal et al., 
1991). The region of homology between mSin3 and yeast 
SIN3 corresponded to the region encompassing the sec- 
ond of four paired amphipathic heffces (PAHs) found in the 
yeast protein (Figure 3). Additional nucleotide sequence 
analysis of partial mouse sin3 cDNA clones isolated from 
a mouse newborn brain cDNA library demonstrated that 
the high degree of amino acid homology extends well be- 
yond the PAH2 region in both directions and includes addi- 
tional PAH-homologous tructures (N. S.-A. and R. A. D., 
unpublished data). Furthermore, screening of Southern 
blots of mouse and human genomic DNA with a mouse 
sin3 PAH2-containing probe revealed the presence of two 
sin3-related loci in each species (data not shown). The 
homolog identified in our studies corresponds to the sin3B 
clone presented in Ayer et al. (1995 [this issue of Cell]). 
To begin to assess the nature of the interaction between 
the repressive domain of MAD or Mxi and the PAH2 region 
of rosin3, we tested yeast transformants bearing various 
GAL4-TAD fus ion  const ructs  
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Figure 4. InteractionsamongProteinsEncodedbyVariousmxi, MAD, 
and sin3 Constructs Expressed in Yeast 
Protein-protein interaction was monitored by a qualitative I%galacto- 
sidase filter assay (Vojtek et al., 1993) in which yeast colonies that 
have been grown under conditions to select for both plasmids turn 
blue upon exposure to 5-bromo-4-chloro-3-indolyl-I~-D-galactopyrano- 
side (X-Gal) if complex formation between the LexA- and GAL4-fused 
proteins occurs and results in transactivation f the integrated bacterial 
lacZ gene. The GAL4-TAD vector was pACT (Clontech); the GAL4- 
TAD fusion constructs contained either a 200 amino acid segment of 
roSin3 encompassing the PAH2 motif (sin3) or the same segment of 
rosin3 with a proline for leucine substitution in helix 1 of PAH2 (sin3- 
pro; see legend to Figure 3). The LexA-DBD fusion constructs, de- 
signed in the vector pBMT116, contained either the entire ORF of 
mouse Mxi-SR (mxi-SR), the entire ORF of Mxi-WR (mxi-WR), the 
entire ORF of mouse Mxi-SR with a proline for leucine substitution at 
residue 19 of the repressive region (mxi-SR-pro), the 36 amino acid 
repressive region of Mxi-SR (mxi-SR-NT), or the 53 amino-terminal 
residues of human MAD (mad-NT). ND, not determined. 
LexA-DBD and GAL4-TAD fusion proteins for activity in 
the 13-galactosidase filter assay. As shown in Figure 4, a 
marked difference in the interaction was observed for the 
two mouse mxil cDNA forms as evidenced by a LacZ + 
phenotype for the Mxi-SR plus mSin3 transformants, but 
not for the Mxi-WR plus mSin3 transformants. LacZ as- 
says of transformants with other combinations of plasmids 
showed that the interaction between the GAL4-mSin3 pro- 
tein and a LexA bait containing either the full-length Mxi- 
SR or the 36 amino acid repressive domain of Mxi-SR 
(Mxi-SR-NT) was found to be comparable to that observed 
between mSin3 and the amino-terminal region of human 
MAD (Mad-NT in Figure 4). In addition, a proline for leucine 
substitution at position 19 in Mxi-SR (this residue is pre- 
dicted to lie on the hydrophobic interface of the c~-helical 
repression domain; see Figure 1B) markedly diminished 
~-galactosidase activity (Mxi-SR-pro plus Sin3 in Figure 
4). Similarly, a proline for leucine substitution in helix 1 of 
the mSin3 PAH2 motif (see residue marked with an aster- 
isk in Figure 3) abolished the interaction with the Mxi re- 
pressive region (Mxi-SR-NT plus Sin3-pro in Figure 4). An 
unanticipated observation in these yeast studies was the 
finding that the LexA-Mxi-SR bait appeared incapable of 
interacting with GAL4-TAD-Max (data not shown). Our 
ability to detect he Mxi-SR-Max interaction in mammalian 
cells (see below), but not by the two-hybrid system in yeast, 
may point to deficiencies in the latter esulting from the 
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Figure 5. Interaction among Proteins Encoded 
by Various taxi, sin3, and max Expression Con- 
structs in Mammalian Cells 
Each 10 cm plate of COS7 cells was lipofected 
with 5 p.g of the various expression constructs 
(described in Experimental Procedures)shown 
above the lanes either singly or in combination. 
Radiolabeled whole-cell extracts were immu- 
noprecipitated under high (ionic detergents; 
lanes 13-14 of [A]) or low (nonionic detergents; 
remainder of the lanes in [A] and [B]) stringency 
conditions as described previously (Blackwood et al., 1992) using either the anti-Myc tag monoclonal antibody 9E10, the anti-HA tag monoclonal 
antibody 12CA-5, or the polyclonal anti-Max carboxy-terminal antibody described in Experimental Procedures. The Myc-tagged Mxi-SR signal in 
lane 13 in (A) and signals from endogenous Max in lysates immunoprecipitated with the anti-Max antibody are clearly apparent upon longer 
exposure. The relative molecular masses of immunoprecipitated proteins were 21 kDa for Max, 28 kDa for HA-tagged Sin3, and 35 kDa for 
Myc-tagged Mxi-SR. 
absence of mammalian factors (such as chaperonins) in- 
volved in regulating protein-protein interactions. Alterna- 
tively, since baits for either Mxi-SR-pro or Mxi-WR were 
capable of interacting with GAL4-TAD-Max in yeast, 
there may be intramolecular interactions in the LexA-Mxi- 
SR fusion protein between its repressive and its HLH- 
LZ domains that preclude intermolecular association with 
Max. 
Having shown that the repressive region of Mxil inter- 
acts specifically with the PAH2-containing domain of the 
mSin3 homolog when expressed in yeast, we next as- 
sessed whether this association could occur in mamma- 
lian cells. Subconfluent COS7 monolayers were cotrans- 
fected with various combinations of expression constructs 
encoding Mxi-SR fused at its carboxyl terminus to a Myc 
epitope tag, encoding the Sin3 PAH2-containing region 
joined to an amino-terminal hemagglutinin (HA) epitope 
tag, or encoding mouse Max. Whole-cell extracts were 
prepared from metabolically labeled transfected cultures 
and subjected to immunoprecipitation reactions under low 
or high stringency conditions (see Experimental Proce- 
dures). 
As shown in Figure 5A, each of the antibodies utilized 
immunoprecipitated a protein of expected size (28 kDa 
HA-tagged Sin3, 35 kDa Myc-tagged Mxi-SR, and 21 kDa 
Max; lanes 4, 7, and 10), but only when the appropriate 
expression construct was added to the transfection (Fig- 
ure 5A, lanes 1-3, 5-6, 8-9, and 11-12). In cotransfec- 
tions, the anti-HA tag antibody immunoprecipitated Myc- 
tagged Mxi-SR when coexpressed with HA-tagged Sin3 
and, conversely, the anti-Myc tag antibody immunopre- 
cipitated HA-tagged Sin3 when cotransfected with Myc- 
tagged Mxi-SR under low and high stringency conditions 
(Figure 5A, lanes 13-16; Mxi band in lane 13 is observable 
upon longer exposure). The Mxi-Max association, detect- 
able only under low stringency, was shown by the appear- 
ance of the Max protein in the anti-Myc tag precipitate 
and by the Myc-tagged Mxi-SR protein in the anti-Max 
precipitate (Figure 5A, lanes 17-18; high stringency data 
not shown). These low stringency conditions, which in- 
volve the use of buffers containing only nonionic deter- 
gents, were shown previously to preserve the c-MYC- 
MAX complex that is disrupted by the addition of SDS and 
deoxycholate (Blackwood et al., 1992). Most importantly, 
since a Max-Sin3 association fails to occur in cells doubly 
transfected with max and HA-tagged sin3 expression con- 
structs (Figure 5A, lanes 19-20), the appearance of Sin3 
in anti-Max immunoprecipitates of cells triply transfected 
with Myc-tagged mxi-SR, HA-tagged sin3, and max indi- 
cates that the three proteins exist in a ternary complex in 
vivo (Figure 5A, lane 21; also see Figure 5B, lane 1). 
Finally, to substantiate results obtained in yeast small- 
scale transformations (see Figure 4) with respect to speci- 
ficity of the interaction between various Sin3 and Mxi deriv- 
atives, we assessed various mutant expression constructs 
for interaction by im munoprecipitation ofcotransfected ex- 
tracts (Figure 5B). These studies showed that Sin3-pro 
could not form a complex with Max and Mxi-SR (Figure 
5B, lane 2) and that Mxi-SR-pro could associate with Max 
but not with Sin3 (Figure 5B, lanes 3-5). 
Discuss ion 
In this study, the characterization of two mouse mxi l  tran- 
script forms has allowed us to develop a better understand- 
ing of the molecular basis of the anti-Myc actions of Mxil 
and of the functional interrelationships among members 
of the Myc superfamily. The two transcripts, arising from 
a single mouse mxi l  gene, differ in their capacity to encode 
a 36 residue amino-terminal extension. By using these 
alternative Mxil  protein forms and various mutant deriva- 
tives in a powerful and well-established assay for Myc func- 
tion, we have established that this extension serves as a 
modular domain essential for potent anti-oncogenic activ- 
ity. A key role for this region is also suggested by its high 
degree of structural conservation, both between phylo- 
genetically distant Mxil proteins (Zervos et al., 1993; 
Schreiber-Agus et al., 1994) and with the similarly sup- 
pressive MAD protein (Ayer et al., 1993; Lahoz et al., 
1994). Although a data base homology search failed to 
provide any obvious clues about the function of this do- 
main, its conserved capacity for secondary structure for- 
mation (and the need to maintain helicity for full activity; 
see Mxi-SR-pro in Figure 2B) and its strong affinity for a 
mammalian homolog of yeast SIN3 in vivo suggest that 
its repressive actions may be executed through protein- 
protein interactions. 
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Substantial structural homology between mammalian 
and yeast SIN3 implies conservation of functional proper- 
ties as well. For the yeast protein, documented properties 
include nuclear localization, inability to bind DNA directly, 
potential to associate with other factors through four PAHs 
(analogous to the HLH dimerization motifs), and, finally, 
ability to repress transcription of a diverse set of target 
genes (Wang et al., 1990; Vidal et al., 1991; Wang and 
Stillman, 1993, and references therein). Although yeast 
SIN3 also has been shown in some contexts to be involved 
in transcriptional activation (Vidal et al., 1991; Yoshimoto 
et al., 1992), this effect is likely indirect in nature (Wang 
and Stillman, 1993). With respect to mammalian Sin3, the 
tethering of this putative transcriptional modulator, through 
its PAH2 domain, to promoters of key growth genes may 
occur through the Mxi-Max heterodimeric omplex. Once 
in the context of a promoter, Sin3 may exert its repressive 
effects by modifying the activity of other transcriptional 
regulators or by maintaining the surrounding chromatin in 
a repressed heterochromatic state (Vidal et al., 1991; 
Wang and Stillman, 1993; for review on transcriptional 
repressors, see Cowell, 1994). Interactions with other tran- 
scriptional regulators or factors of the general transcription 
machinery could occur through the three additional PAH 
motifs, with Sin3 serving as a scaffold for formation of 
a higher order repressive complex (Wang and Stillman, 
1993). 
Our observations with respect to the requirement of the 
amino-terminal extension for full suppressivity (Figure 2B) 
and to the formation of an Mxi-Sin3-Max ternary complex 
in vivo (Figure 5) have prompted us to reexamine the pre- 
vailing view of how Myc activity is regulated by Mxil or 
Mad (for review see Amati and Land, 1994). In the current 
model, regulation of Myc-responsive genes is thought to 
involve the titration by Mxi of a limited intraceltular pool 
of Max and the occupation (as an Mxi-Max heterodimer) 
of consensus recognition sequences in promoters of com- 
monly regulated genes. Once bound, the transactivation- 
incompetent Mxi-Max heterodimer could serve to deny 
access to the active Myc-Max complex (Ayer et al., 1993; 
Ayer and Eisenman, 1993; Zervos et al., 1993; Lahoz et 
al., 1994; for review see Amati and Land, 1994). The obser- 
vation that Mxi-WR possessed only modest repressive po- 
tential (despite having the identical bHLH-LZ region as 
Mxi-SR and thus being able to complex with Max and bind 
consensus sites) argues against the simple view that Mxi 
regulates Myc activity in such a passive manner. Rather, 
since the ability of a given Mxil complex to antagonize 
fully Myc function requires activities encoded within the 
amino-terminal region, Mxi-SR (as well as MAD; see Ayer 
et al., 1995) appears to play a more active role in negative 
regulation. The findings of this study lead us to speculate 
that this regulation is achieved through the recruitment, 
by the ternary complex, of specific proteins that together 
mediate transcriptional repression of Myc-responsive gene 
targets. 
Comparison of steady-state mRNA expression of Mxi- 
SR, Mxi-WR, and Myc during embryogenesis and in new- 
born and adult tissues (data not shown) has provided in- 
sight into how these three proteins functionally relate one 
to another during development. First, in accordance with 
findings made in cell culture-based ifferentiation systems 
(Zervos et al., 1993), we have observed declining levels 
of c-myc mRNA (as described previously by Zimmerman 
et al., 1986) and constant or increasing levels of mxil-SR 
(N. S.-A. and R. A. D., unpublished data) with progressive 
development and growth arrest in many organs of the 
mouse. This concurs with previous hypotheses tating that 
while proliferative processes may correlate with the acti- 
vated expression of growth-promoting genes by the Myc- 
Max complex, events associated with differentiation may 
involve repression of genes in the same or related pathways 
by Mxi-Max or Mad-Max (Ayer and Eisenman, 1993; Zervos 
et al., 1993; for review see Amati and Land, 1994). Growth 
arrest/terminal differentiation presumably prompted by 
Mxi-SR may be, under specific physiological circum- 
stances, delayed or prevented by the weakly repressive 
Mxi-WR. For instance, although mxi-WR levels were ob- 
served to be significantly lower than those of mxi-SR in 
tissues that have nearly completed their differentiation 
programs, transcripts of the two forms were nearly compa- 
rable in amount during the midgestational stages of em- 
bryogenesis (N. S.-A. and R. A. D., unpublished data). 
During this period of dwindling cellular growth but contin- 
ued active differentiation, Mxi-WR may attenuate the re- 
pressive properties of Mxi-SR by competing for common 
target sequences, accessory proteins, or both through 
their shared carboxy-terminal regions. 
A role for Mxi-SR in normal growth and development 
and in cancer pathogenesis gains support from many of 
the biochemical and biological features described in this 
study. These features include anti-Myc transformation ac- 
tivity (also see Lahoz et al., 1994; Schreiber-Agus et al., 
1994), interaction with a putative transcriptional repressor, 
reciprocal pattern of expression between mxi-SR and myc 
with respect to growth and differentiation (Zervos et al., 
1993; Larsson et al., 1994; N. S.-A. and R. A. D., unpub- 
lished data), and mapping to a chromosomal location 
(10q24-26) that is a common target for cytogenetic lesions 
found in several human malignancies, including mela- 
noma, prostate cancer, glioblastoma multiforme, and leu- 
kemia/lymphoma (Edelhoff et al., 1994). Specifically, Mxil 
may act as a growth suppressor whose loss of function 
could serve as an important event in the development of 
some naturally occurring human cancers. In this regard, 
it is intriguing that the mouse sin3 gene maps to a chromo- 
somal position that is distinct from that of mxi (J. M. Ro- 
chelle, M. F. Seldin, and R. A. D., unpublished data) and 
that is highly syntenic to a human chromosomal region 
cytogenetically involved in tumors similar in type to those 
involving the MXl locus. Concordance in the tumor types 
associated with these two distinct loci lends additional ge- 
netic evidence that mxil and sin3 are functionally linked 
to each other. Finally, observations made in this study call 
for tumor surveys that take into account not only those 
lesions that disrupt the mxil or mouse sin30RF, but also 
those that result in a regulated switch from strongly to 
weakly repressive mxi transcript forms. 
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Experimental Procedures 
Isolation of Genomic and cDNA Clones and Analysis 
of DNA and Putative Proteins 
For the isolation of mouse mxil-related sequences, three human MX/1 
probes were used to screen at low stringency an amplified Mbol partial 
mouse genomic library in Charon 35A, an oligo(dT)-primed ;~gtl0 
cDNA library generated from RNA derived from MEL cell cultures 18 
hr after induction with hexamethylene bisacetamide (Cheng and 
Skoultchi, 1989), and an oligo(dT)- and random-primed XZAPII cDNA 
library generated from RNA derived from mouse newborn brain (Stra- 
tagene). The human MXI1 probes included a 315 bp bHLH-LZ- 
encoding Pstl fragment, a 200 bp PCR-generated probe correspond- 
ing to the 5'-most region, and an 1100 bp Sspl fragmen t containing 
3'UTR sequences (the human MXI1 cDNA clone was provided by R. 
Brent [Zervos et al., 1993]). Purification of recombinant clones, sub- 
cloning, probe preparation and radiolabeling, and blotting and hybrid- 
izations were performed as described previously (Sambrook et al., 
1989). Nucleotide sequence was determined by Sequenase (U. S. 
Biochemicals) and partial chemical degradation (Maxam and Gilbert, 
1980) and was analyzed with the Genetics Computer Group sequence 
analysis software package (Devereux et al., 1984). 
Expression Constructs and REF Cooperation Assays 
Expression constructs for mouse mxil-WR and mouse mxi-SR were 
generated by placing their respective cDNAs in the sense orientation 
relative to two tandemly repeated Moloney murine leukemia virus long 
terminal repeats in pVNic (Schreiber-Agus et al., 1993), a derivative 
of the pVcos7 vector (Yancopoulos et al., 1985). The human MXI1 
expression construct contained the 2.4 kb EcoRI cDNA insert de- 
scribed elsewhere (Zervos et al., 1993) subcloned into the pVcos7 
vector in the sense orientation relative to the long terminal repeats 
(Lahoz et al., 1994). To make the mouse mxil-Arep construct, a 120 
bp PCR-generated fragment encoding mouse Mxi-SR 5'UTR and the 
first three codons of Mxi-SR was ligated in-frame to a 630 bp PCR- 
generated fragment hat encoded amino acids 34-228 of Mxi-SR; the 
resultant fragment (deleted for Mxi-SR amino acids 4-33) was sub- 
cloned in pVNic in the sense orientation. Mxil-SR-pre is identical to 
the mxil-SR expression construct except that Leu-19 was converted 
to a proline residue by PCR-based site-directed mutagenesis, a modifi- 
cation confirmed by nucleotide sequence analysis. The construct max- 
rep was made by ligating a 330 bp EcoRI-Bglll fragment from mxi-SR 
containing 5'UTR and repressive region-encoding sequences in-frame 
to a PCR-generated 430 bp BgllI-Sall fragment from mouse max en- 
coding its ORF from the basic region (amino acid 16 of MaxA9) to the 
terminator and a 1300 bp SalI-EcoRI fragment from the mouse max 
3'UTR (the template CMV-max was provided by E. Ziff); the resultant 
chimeric gene was subcloned into pVNic. As a control for max-rep, a 
1.8 kb HindllI-EcoRI fragment of the max cDNA encoding the MaxA9 
protein was subcloned into pVNic. The mouse c-myc expression con- 
struct, pKO-myc (Mukherjee et al., 1992), contains exons 2 and 3 of 
the mouse c-myc genomic clone driven by a simian virus 40 promoter/ 
enhancer element, pT24-ras encodes the mutant H-RAS (Val-12) onco- 
gene (Fasano et al., 1983). Early passage cultures of REFs were pre- 
pared and cotransfected by the calcium phosphate precipitation 
method as described previously (Mukherjee et al., 1992). 
Yeast Two-Hybrid Screens 
To identify cellular proteins that interact with the highly conserved 
amino-terminal repressive regions of MAD and Mxi-SR, a mouse T 
cell lymphoma Matchmaker cDNA library in the vector pACT (Clontech) 
was introduced into the Saccharomyces cerevisiae L40 reporter strain 
bearing the MAD-NT-LexA fusion plasmid (LexA plasmid pBMT116 
was provided by R. Sternglanz; construct is described in the legend to 
Figure 4) using a modified version (Vojtek et al., 1993) of the two-hybrid 
system developed by Fields and Song (1989). Standard manipulations 
of yeast were performed essentially as described (Schreiber-Agus et 
al., 1994). Transformants were plated onto synthetic media plates lack- 
ing histidine, leucine, tryptophan, uracil, and lysine and containing 25 
mM 3-aminotriazole, a chemical inhibitor of imidazole glycerol phos- 
phate dehydratase, which restores histidine auxotrophy (Durfee et al., 
1993). His + colonies were assayed for ~-galactosidase activity by a 
qualitative filter assay (Vojtek et aL, 1993), and DNA isolated from 
transformants with the His + LacZ + phenotype was electroporated into 
HB101 cells on synthetic media lacking leucine. The pACT inserts 
were sequenced with a GAL4 TAD-specific primer (5;CTATTCGA- 
TGATGAAGATACCCCACC-3~. To examine interactions between var- 
ious Mxi- or MAD-LexA fusion proteins and mSin3-GAL4 or mouse 
Max-GAL4 fusion proteins, we introduced plasmids shown in Figure 4 
successively into the L40 reporter strain by small-scale transformation, 
and ~-galactosidase activity of the double transformants was deter- 
mined by filter assay as described previously (Schreiber-Agus et al., 
1994). 
Immunoprecipitation 
COS7 cells were transfected with 5 I~g each of the appropriate xpres- 
sion constructs indicated in Figure 5 and 100 p.g of LipofectAMINE 
reagent (GIBCO BRL), allowed to grow for an additional 40 hr, and 
metabolically labeled using the EXPRE~S3sS protein-labeling mix (Du- 
Pont-New England Nuclear) for 4 h r. Immunoprecipitations under high 
and low stringency conditions were performed as described (Black- 
wood et al., 1992), and samples were resuspended in SDS loading 
buffer, analyzed on 12.5% SDS-polyacrylamide gels, and visualized 
by autoradiography. To generate the Myc-tagged mxi-SR construct, 
we subcloned the mxi-SR ORF into the pJFE14 expression vector that 
provides a triple Myc epitope tag (EQKLISEEDL) at the carboxy- 
terminal end of the protein (Davis et al., 1994; pJFE14 was a gift 
from G. Yancopoulos). A similarly designed sin3 expression construct 
(HA-tagged sin3) encoded an amino-terminal nti-influenza HA epitope 
tag (YPYDVPDYA) (Cortes et al, 1994) fused to a 200 amino acid 
segment of mouse sin3 containing the PAH2 structure. The Myc- 
tagged Mxi-SR-pro and Sin3-pro expression constructs contained pro- 
line for leucine substitutions at positions shown in Figures 1B and 3, 
respectively. CMV-max was used in the max transfections. The anti- 
Myc tag antibody is the mouse monoclonal antibody 9E10 (Oncogene 
Science); the monoclonal antibody directed to the HA peptide, 12CA-5, 
was provided as ascites fluid through the Albert Einstein College of 
Medicine Cancer Center hybridoma facility (M. Scharff and S. Buhl); 
and the polyclonal Max antibody was aCT (a gift from E. Ziff). 
Acknowledgments 
Correspondence should be addressed to R. A. D. The authors thank 
Drs. Bob Eisenman and Don Ayer for discussing unpublished data on 
roSin3, Drs. George Yancopoulos and Scott Mellis for helpful com- 
ments, Jolaine Lauridsen for assistance in manuscript preparation, 
and Joe DePinho for graphic illustration. N. S.-A. is supported by Na- 
tional Institutes of Health (NIH) training grants T32GM07128 and 
2T32AG00194. K. C. was supported by March of Dimes research grant 
1-FY93-0746. R. T. was supported by NIH training grant RT32CA- 
09173. G. R. and A. I. S. are supported by NIH grant 5R37CA16368. 
R. A. D. is a recipient of an American Heart Association Investigator 
Award and is supported by NIH grants RO1-EY09300 and HD28317. 
Support was also derived from American Cancer Society basic re- 
search grant DB117 and National Cancer Institute Cancer Center grant 
2P30CA13330. 
Received November 22, 1994; revised January 26, 1995. 
References 
Amati, B., and Land, H. (1994). Myc-Max-Mad: a transcription factor 
network controlling cell cycle progression, differentiation and death. 
Curr. Opin. Genet. Dev. 4, 102-108. 
Amati, B., Littlewood, T. D., Evan, G. I., and Land, H. (1993a). The 
c-Myc protein induces cell cycle progression and apoptosis through 
dimerization with Max. EMBO J. 12, 5083-5087. 
Amati, B., Brooks, M. W., Levy, M., Littlewood, T. D., Evan, G. I., and 
Land, H. (1993b). Oncogenic activity of the c-Myc protein requires 
dimerization with Max. Cell 72, 233-245. 
Ayer, D. E., and Eisenman, R. N. (1993). A switch from Myc:Max to 
Mad:Max heterocomplexes accompanies monocyte/macrophage dif- 
ferentiation. Genes Dev. 7, 2110-2119. 
Ayer, D. E., Kretzner, L., and Eisenman, R. N. (1993). Mad: a hetero- 
Functional Analysis of Mxil Repression 
785 
dimeric partner for Max that antagonizes Myc transcriptional activity. 
Cell 72, 211-222. 
Ayer, D. E., Lawrence, Q. A., and Eisenman, R. N. (1995). Mad-Max 
transcriptional repression is mediated by ternary complex formation 
with mammalian homologs of yeast reprassor Sin& Cell 80, this issue. 
Bello-Fernandez, C., Packham, G., and Cleveland, J. L. (1993). The 
ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. 
Natl. Acad. Sci. USA 90, 7804-7808. 
Berberich, S. J., and Cole, M. D. (1992). Casein kinase II inhibits the 
DNA-binding activity of Max homodimers but not Myc/Max heterodi- 
mers. Genes Dev. 6, 166-176. 
Blackwell, T. K., Kretzner, L., Blackwood, E. M., Eisenman, R. N., and 
Weintraub, H. (1990). Sequence-specific DNA binding by the c-Myc 
protein. Science 250, 1149-1151. 
Blackwood, E. M., and Eisenman, R. N. (1991). Max: A helix-loop-helix 
zipper protein that forms a sequence-specific DNA binding complex 
with Myc. Science 251, 1211-1217. 
Blackwood, E. M., Luscher, B., and Eisenman, R. N. (1992). Myc and 
Max associate in vivo. Genes Dev. 6, 71-80. 
Cheng, G., and Skoultchi, A. I. (1989). Rapid induction of polyadeny- 
lated H1 histone mRNAs in mouse erythroleukemia cells is regulated 
by c-myc. Mol. Cell. Biol. 9, 2332-2340. 
Cortes, P., Ye, Z.-S., and Baltimore, D. (1994). RAG-1 interacts with 
the repeated amino acid motif of the human homologue of the yeast 
protein SRPI. Proc. Natl. Acad. Sci. USA 91, 7633-7637. 
Cowell, I. G. (1994). Repression versus activation in the control of 
gene transcription. Trends Biochem. Sci. 19, 38-42. 
Davis, S., Gale, N. W., Aldrich, T. H., Maisonpierre, P. C., Lhotak, V., 
Pawson, T., Goldfarb, M., and Yancopoulos, G. D. (1994). Ligands 
for EPH-related receptor tyrosine kinases that require membrane at- 
tachment or clustering for activity. Science 266, 816-819. 
Devereux, J., Haeberli, P., and Smithies, O. (1984). A comprehensive 
set of sequence analysis programs for the VAX. Nucl. Acids Res. 12, 
387-395. 
Durfee, T., Becherer, K., Chen, P.-L., Yeh, S.-H., Yang, Y., Kilburn, 
A. E., Lee, W.-H., and Elledge, S. (1993). The retinoblastoma protein 
associates with the protein phosphatase type 1 catalytic subunit. 
Genes Dev. 7, 555-569. 
Edelhoff, S., Ayer, D. E., Zervos, A. S., Steingrimsson, E., Jenkins, 
N. A., Copeland, N. G., Eisenman, R. N., Brent, R., and Disteche, 
C. M. (1994). Mapping of two genes encoding members of a distinct 
subfamily of MAX interacting proteins: MAD to human chromosome 
2 and mouse chromosome 6, and MXI1 to human chromosome 10 
and mouse chromosome 19. Oncogene 9, 665-668. 
Evan, G. I., and Littlewood, T. D. (1993). The role of c-myc in cell 
growth. Curr. Biol. 3, 44-49. 
Fasano, O., Taparowsky, E., Fiddes, J., Wigler M., and Goldfarb, M. 
(1983). Sequence and structure of the coding region of the human 
H-ras-1 gene from T24 bladder carcinoma cells. J. Mol. Appl. Genet. 
2, 173-180. 
Ferre-D'Amare, A. R., Prendergast, G. C., Ziff, E. B., and Burley, S. K. 
(1993). Recognition by Max of its cognate DNA through a dimeric 
b/HLH/Z domain. Nature 363, 38-45. 
Fields, S., and Song, O. (1989). A novel genetic system to detect 
protein-protein interactions. Nature 340, 245-246. 
Fisher, D. E., Parent, L. A., and Sharp, P. A. (1993). High affinity 
DNA-binding Myc analogs: recognition by an (~ helix. Cell 72, 467- 
476. 
Jansen-Durr, P., Meichle, A., Steiner, P., Pagano, M., Finke, K., Botz, 
J., Wessbecher, J., Draetta, G,, and Eilers, M. (1993). Differential mod- 
ulation of cyclin gene expression by Myc. Proc. Natl. Acad. Sci. USA 
90, 3685-3689. 
Kato, G. J., and Dang, C. V. (1992). Function of the c-Myc oncoprotein. 
FASEB J. 6, 30565-30572. 
Kato, G. J., Barret, J., Villa-Garcia, M., and Dang, C. V. (1990). An 
amino-terminal c-Myc domain required for neoplastic transformation 
activates transcription. Mol. Cell. Biol. 10, 5914-5920. 
Kato, G. J., Lee, W. M. F., Chen, L., and Dang, C. V. (1992). Max: 
functional domains and interaction with c-Myc. Genes Dev. 6, 81-92. 
Kretzner, L., Blackwood, E. M., and Eisenman, R. N. (1992). Myc and 
Max proteins possess distinct transcriptional activities. Nature 359, 
426-429. 
Lahoz, E. G., Xu, L., Schreiber-Agus, N., and DePinho, R. A. (1994). 
Suppression of Myc, but not Ela, transformation activity by Max- 
associated proteins, Mad and Mxil. Proc. Natl. Acad. Sci. USA 91, 
5503-5507. 
Land, H., Parada, L. F., and Weinberg, R. A. (1983). Tumorigenic 
conversion of primary embryo fibroblasts requires at least two cooper- 
ating oncogenes. Nature 304, 596-602. 
Larsson, L. G., Pettersson, M, Oberg, F., Nilsson, K., and Luscher, 
B. (1994). Expression of mad, mxil, max and c-myc during induced 
differentiation of hematopoietic ells: opposite regulation of mad and 
myc. Oncogene 9, 1247-1252. 
Makela, T. P., Koskinen, P. J., Vastrik, I., and Alitalo, K. (1992). Alterna- 
tive forms of Max as enhancers or suppressors of Myc-Ras cotransfor- 
mation. Science 256, 373-376. 
Maxam, A., and Gilbert, W. (1980). Sequencing end-labeled DNA with 
base-specific chemical cleavages. Moth. Enzymol. 65, 499-560. 
Morgenbesser, S. D., and DePinho, R. A. (1994). Use of transgenic 
mice to studymyc family gone function in normal mammalian develop- 
ment and in cancer. Semin. Cancer Biol. 5, 21-36. 
Mukherjee, B., Morgenbesser, S. D., and DePinho, R. A. (1992). Myc- 
family oncoproteins function through a common pathway to transform 
normal cells in culture: cross interference by Max and trans-acting 
dominant mutants, Genes Dev. 6, 1480-1492. 
Nasmyth, K., Stillman, D., and Kipling, D. (1987). Both positive and 
negative regulators of HO transcription are required for mother cell- 
specific mating-type switching in yeast. Cell 48,579-587. 
Prendergast, G. C., Lawe, D,, and Ziff, E. B. (1991). Association of 
Myn, the murine homolog of Max, with c-Myc stimulates methylation- 
sensitive DNA Binding and Ras cotransformation. Cell 65, 395-407. 
Prendergast, G. C., Hopewell, R., Gorham, B. J., and Ziff, E. B. (1992). 
Biphasic effect of Max on Myc cotransformation activity and depen- 
dence on amino- and carboxy4erminal Max functions. Genes Dev. 6, 
2429-2439. 
Roy, A. L., Carruthers, C., Gutjahr, T., and Roder, R. G. (1993). Direct 
role for Myc in transcription initiation mediated by interactions with 
TFII-I. Nature 365, 359-361. 
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). Molecular Clon- 
ing: A Laboratory Manual, Second Edition (Cold Spring Harbor, New 
York: Cold Spring Harbor Laboratory Press). 
Sawyers, C. L., Callahan, W., and Witte, O. N. (1992). Dominant nega- 
tive MYC blocks transformation by ABL oncogenes. Cell 70, 901-910. 
Schreiber-Agus, N., Torres, R., Homer, J., Lau, A., Jamrich M., and 
DePinho, R. A. (1993). Comparative analysis of the expression and 
oncogenic activities of Xenopus c-, N- and L-myc homologues. Mol. 
Cell. Biol. 13, 2456-2488. 
Schreiber-Agus, N., Chin, L., Chen, K., Torres, R., Thomson, C,, Sac- 
chettini, J. C., and DePinho, R. A. (1994). Evolutionary relationships 
and functional conservation among vertebrate Max-associated pro- 
teins: the zebra fish homolog of Mxil. Oncogene 9, 3167-3177. 
Serrano, M., Lahoz, E. G., DePinho, R. A., Beach, D., and Bar-Sagi, 
D. (1995). pl 6 indu oes cell cycle arrest and inhibits cellular transforma- 
tion. Science 267, 249-252. 
Sternberg, P. W., Stern, M. J., Clark, I., and Herskowitz, I. (1987). 
Activation of the yeast HO gone by release from multiple negative 
controls. Cell 48, 567-577. 
Strich, R., Slater, M. R., and Esposito, R. E. (1989). Identification of 
negative regulatory genes that govern the expression of early meiotic 
genes in yeast. Proc. Natl. Acad. Sci. USA 86, 10018-10022. 
Torres, R., Schreiber-Agus, N., Morgenbesser, S. D., and DePinho, 
R. A. (1992). Myc and Max: a putative transcriptional complex in search 
of a cellular target. Curt. Opin. Cell Biol. 4, 468-474. 
Vidal, M, Strich, R., Esposito, R. E., and Gaber, R. F. (1991). RPD1 
(SIN3/UME4) is required for maximal activation and repression of di- 
verse yeast genes. Mol. Cell. Biol. 11, 6306-6316. 
Cell 
786 
Vojtek, A. B., Hollenberg, S. M., and Cooper, J. A. (1993). Mammalian 
Ras interacts directly with the serine/threonine kinase Raf. Cell 74, 
205-214. 
Wang, H., and Stillman, D. J. (1993). Transcriptional repression in 
Saccharomyces cerevisiae by a SIN3-LexA fusion protein. Mol. Cell. 
Biol. 13, 1805-1814. 
Wang, H., Clark, I., Nicholson, P. R., Herskowitz, I., and Stillman, 
D. J. (1990). The Saccharomyces cerevisiae SIN3 gene, a negative 
regulator of HO, contains four paired amphipathic helix motifs. Mol. 
Cell. Biol. 10, 5927-5936. 
Yancopoulos, G. D., Nisen, P. D., Tesfaye, A., Kohl, N. E., Goldfarb, 
M. P., and AIt, F. W. (1985). N-myc can cooperate with res to transform 
normal cells in culture. Proc. Natl. Acad. Sci. USA 83, 5455-5459. 
Yoshimoto, H., Ohmae, M., and Yamashita, I. (1992). The Saccharo- 
myces cerevisiae GAM2/SlN3 protein plays a role in both the activation 
and repression of transcription. Mol. Gen. Genet. 233, 327-330. 
Zervos, A. S., Gyuris, J., and Brent, R. (1993). Mxil, a protein that 
specifically interacts with Max to bind Myc-Max recognition sites. Cell 
72, 223-232. Erratum: Cell 79(2). 
Zimmerman, K. A., Yancopoulos, G. D., Collum, R. G., Smith, R. K., 
Kohl, N. E., Denis, K. A., Nau, M. M., Witte, O. N., Toran-Allerand, D., 
Gee, C. E., Minna, J. D., and AIt, F. W. (1986). Differential expression of 
myc family genes during murine development, Nature 319, 780-783. 
GenBank Accession Numbers 
The accession numbers for the murine taxi1 transcripts reported in 
this paper are L38821 for mxi.WR and L38822 for mxi-SR. 
